Medicare Enrolled

Dr. Brian Apatoff, MD

Neurology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
401 E 55TH ST, New York, NY 10022
2125936262
In practice since 2006 (19 years)
NPI: 1528155611 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Apatoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Apatoff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Apatoff

Dr. Brian Apatoff is a neurology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Apatoff performed 15,425 Medicare services across 398 unique beneficiaries.

Between the years covered by Open Payments, Dr. Apatoff received a total of $348,699 from 42 pharmaceutical and/or device companies across 1270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Apatoff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in NY $348,699 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,425
Medicare services
Top 6% in NY for neurology
398
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~812 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Ocrelizumab infusion (Ocrevus) for MS 14,400 $47 $68
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
440 $4 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
209 $78 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
186 $43 $60
5% dextrose/normal saline (500 ml = 1 unit) 59 $1 $10
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
47 $123 $2,000
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
43 $26 $1,200
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $102 $400
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
20 $8 $10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
93.7% high complexity
3.1% medium
3.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$348,699
Total received (2018-2024)
Avg $49,814/year across 7 years
Top 3% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$331,201 (95.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,781 (4.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,717 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,953
2023
$31,273
2022
$75,201
2021
$57,346
2020
$48,265
2019
$51,434
2018
$64,227

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
TG Therapeutics, Inc.
$7,537
Amgen Inc.
$6,679
EMD Serono, Inc.
$2,836
E.R. Squibb & Sons, L.L.C.
$1,739
Novartis Pharmaceuticals Corporation
$434
Celgene Corporation
$373
PFIZER INC.
$268
Genentech USA, Inc.
$268
Alexion Pharmaceuticals, Inc.
$217
Biogen, Inc.
$205
ABBVIE INC.
$178
Lundbeck LLC
$77
BANNER LIFE SCIENCES, LLC
$39
ARGENX US, INC.
$33
Acorda Therapeutics, Inc
$29
Lilly USA, LLC
$22
Teva Pharmaceuticals USA, Inc.
$21
Top 3 companies account for 81.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$145,506
EMD Serono, Inc.
$66,940
E.R. Squibb & Sons, L.L.C.
$36,486
Genentech USA, Inc.
$29,131
Horizon Therapeutics plc
$25,014
Celgene Corporation
$16,666
Amgen Inc.
$7,931
TG Therapeutics, Inc.
$7,537
Novartis Pharmaceuticals Corporation
$4,673
AbbVie Inc.
$1,125
Janssen Pharmaceuticals, Inc
$1,078
Alexion Pharmaceuticals, Inc.
$1,061
GENZYME CORPORATION
$903
PFIZER INC.
$639
Teva Pharmaceuticals USA, Inc.
$591
ABBVIE INC.
$520
Sentynl Therapeutics, Inc.
$368
UCB, Inc.
$330
Banner Life Sciences, LLC
$293
Scilex Pharmaceuticals Inc.
$184
Biohaven Pharmaceutical Holding Company Ltd.
$170
Allergan, Inc.
$162
Genentech, Inc.
$145
Acorda Therapeutics, Inc
$117
Lilly USA, LLC
$105
Avanir Pharmaceuticals, Inc.
$100
Medtronic, Inc.
$97
Assertio Therapeutics, Inc.
$95
SANOFI-AVENTIS U.S. LLC
$87
ARBOR PHARMACEUTICALS, INC.
$87
Almatica Pharma LLC
$84
Lundbeck LLC
$77
Supernus Pharmaceuticals, Inc.
$73
TG THERAPEUTICS, INC.
$53
SCILEX PHARMACEUTICALS INC.
$48
ASSERTIO THERAPEUTICS, Inc.
$44
Mallinckrodt Hospital Products Inc.
$43
BANNER LIFE SCIENCES, LLC
$39
ARGENX US, INC.
$33
Kowa Pharmaceuticals America, Inc.
$31
Endo Pharmaceuticals Inc.
$20
Boston Scientific Corporation
$16
Top 3 companies account for 71.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AUBAGIO · AUSTEDO · AVALUS · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · COMIRNATY · COPAXONE · Cambia · Corlanor · EMGALITY · Enspryng · GILENYA · GRALISE · Gralise · Horizant · INBRIJA · KESIMPTA · LEMTRADA · LYRICA · Livalo · MAVENCLAD · MAYZENT · Mavenclad · NAPRELAN · NASCOBAL · NUEDEXTA · NURTEC ODT · OCREVUS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · PAXLOVID · PLEGRIDY · Ponvory · QULIPTA · Rebif · Repatha · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · WATCHMAN · XARELTO · ZAVZPRET · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in NY.

Looking for a neurology specialist in New York?
Compare neurologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,291
Per 100K population
79.3
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Apatoff is a mixed practice specialist, with above-average Medicare volume (top 6% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Apatoff experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Apatoff performed 14,400 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Apatoff receive payments from pharmaceutical companies?
Yes. Dr. Apatoff received a total of $348,699 from 42 companies across 1,270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Apatoff's costs compare to other neurologists in New York?
Dr. Apatoff's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Apatoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →